Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
LCI INDUSTRIES
Report date May 19, 2022 · Filed May 23, 2022
Section 16 reporting ended · disclosed 2022-05-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,818 |
Ending reported balance
After 2022-05-19 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-05-19 · Grant · Acquired 1,045 · Balance 27,596 Row 2 · 2022-05-19 · Grant · Acquired 3,222 · Balance 30,818 F1: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs vested upon the conclusion of the director's board service with the Company per the election of the director. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-19 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-05-19 · Exercise / conversion · Disposed 333 · Balance 0 F2: Each Stock Unit represents a contingent right to receive one share of LCII common stock. F1: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs vested upon the conclusion of the director's board service with the Company per the election of the director. F3: No exercisable date for this type of award. F4: No expiration date for this type of award. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-19 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-05-19 · Exercise / conversion · Disposed 285 · Balance 0 F2: Each Stock Unit represents a contingent right to receive one share of LCII common stock. F1: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs vested upon the conclusion of the director's board service with the Company per the election of the director. F3: No exercisable date for this type of award. F4: No expiration date for this type of award. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-19 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-05-19 · Exercise / conversion · Disposed 278 · Balance 0 F2: Each Stock Unit represents a contingent right to receive one share of LCII common stock. F1: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs vested upon the conclusion of the director's board service with the Company per the election of the director. F3: No exercisable date for this type of award. F4: No expiration date for this type of award. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-19 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-05-19 · Exercise / conversion · Disposed 236 · Balance 0 F2: Each Stock Unit represents a contingent right to receive one share of LCII common stock. F1: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs vested upon the conclusion of the director's board service with the Company per the election of the director. F3: No exercisable date for this type of award. F4: No expiration date for this type of award. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-19 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-05-19 · Exercise / conversion · Disposed 409 · Balance 0 F2: Each Stock Unit represents a contingent right to receive one share of LCII common stock. F1: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs vested upon the conclusion of the director's board service with the Company per the election of the director. F3: No exercisable date for this type of award. F4: No expiration date for this type of award. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-19 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-05-19 · Exercise / conversion · Disposed 177 · Balance 0 F2: Each Stock Unit represents a contingent right to receive one share of LCII common stock. F1: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs vested upon the conclusion of the director's board service with the Company per the election of the director. F3: No exercisable date for this type of award. F4: No expiration date for this type of award. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-19 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-05-19 · Exercise / conversion · Disposed 254 · Balance 0 F2: Each Stock Unit represents a contingent right to receive one share of LCII common stock. F1: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs vested upon the conclusion of the director's board service with the Company per the election of the director. F3: No exercisable date for this type of award. F4: No expiration date for this type of award. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-19 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2022-05-19 · Exercise / conversion · Disposed 207 · Balance 0 F2: Each Stock Unit represents a contingent right to receive one share of LCII common stock. F1: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs vested upon the conclusion of the director's board service with the Company per the election of the director. F3: No exercisable date for this type of award. F4: No expiration date for this type of award. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-19 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2022-05-19 · Exercise / conversion · Disposed 202 · Balance 0 F2: Each Stock Unit represents a contingent right to receive one share of LCII common stock. F1: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs vested upon the conclusion of the director's board service with the Company per the election of the director. F3: No exercisable date for this type of award. F4: No expiration date for this type of award. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-19 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2022-05-19 · Exercise / conversion · Disposed 201 · Balance 0 F2: Each Stock Unit represents a contingent right to receive one share of LCII common stock. F1: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs vested upon the conclusion of the director's board service with the Company per the election of the director. F3: No exercisable date for this type of award. F4: No expiration date for this type of award. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-19 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2022-05-19 · Exercise / conversion · Disposed 196 · Balance 0 F2: Each Stock Unit represents a contingent right to receive one share of LCII common stock. F1: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs vested upon the conclusion of the director's board service with the Company per the election of the director. F3: No exercisable date for this type of award. F4: No expiration date for this type of award. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-19 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2022-05-19 · Exercise / conversion · Disposed 167 · Balance 0 F2: Each Stock Unit represents a contingent right to receive one share of LCII common stock. F1: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs vested upon the conclusion of the director's board service with the Company per the election of the director. F3: No exercisable date for this type of award. F4: No expiration date for this type of award. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-19 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2022-05-19 · Exercise / conversion · Disposed 250 · Balance 0 F2: Each Stock Unit represents a contingent right to receive one share of LCII common stock. F1: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs vested upon the conclusion of the director's board service with the Company per the election of the director. F3: No exercisable date for this type of award. F4: No expiration date for this type of award. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-19 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2022-05-19 · Exercise / conversion · Disposed 27 · Balance 0 F2: Each Stock Unit represents a contingent right to receive one share of LCII common stock. F1: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs vested upon the conclusion of the director's board service with the Company per the election of the director. F3: No exercisable date for this type of award. F4: No expiration date for this type of award. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-19 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2022-05-19 · Exercise / conversion · Disposed 1,045 · Balance 0 F2: Each Stock Unit represents a contingent right to receive one share of LCII common stock. F3: No exercisable date for this type of award. F4: No expiration date for this type of award. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs vested upon the conclusion of the director's board service with the Company per the election of the director.
F2: Each Stock Unit represents a contingent right to receive one share of LCII common stock.
F3: No exercisable date for this type of award.
F4: No expiration date for this type of award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2017 Filed Dec 5, 2017 21:25 UTC | LCI INDUSTRIES LCII · Entity 4365 | GrantCommon Stock | 3 | $129.95 | $389.85 |
DisclosureSEC source: 0000763744-17-000314 · wf-form4_151250911160275.xml · nonDerivative · entry 1 Fenech Ronald · CIK 0001481268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634 F1 · shares: 3 shares received as a result of a regular cash dividend of $0.55 per share paid on December 1, 2017 to holders of registrant's common stock on November 17, 2017. In accordance with the registrant's Equity Award and Incentive Plan, holders of restricted stock received additional restricted shares equivalent to $0.55 per restricted share held on November 17, 2017. These shares of Common Stock are restricted, and forfeitable, for a period of 1 year from the original award date. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 21:11 UTC | LCI INDUSTRIES LCII · Entity 4365 | GrantCommon Stock | 631 | $115.60 | $72,943.60 |
DisclosureSEC source: 0000763744-17-000278 · wf-form4_151121226520802.xml · nonDerivative · entry 1 Fenech Ronald · CIK 0001481268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 631 F1 · shares: These shares of Common Stock are restricted, and forfeitable, for a period of 1 year from the award date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.